54
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease

, , , , , & show all
Pages 455-461 | Published online: 03 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

L.C. Nijdam, M.D.M. Assink, J.C. Kuijvenhoven, M.E.A. de Saegher, P.D.L.P.M. van der Valk, J. van der Palen, M.G.J. Brusse-Keizer & K.L.L. Movig. (2016) Safety and Tolerability of Nebulized Amoxicillin-Clavulanic Acid in Patients with COPD (STONAC 1 and STONAC 2). COPD: Journal of Chronic Obstructive Pulmonary Disease 13:4, pages 448-454.
Read now

Articles from other publishers (3)

Kristian Bagge, Pradeesh Sivapalan, Josefin Eklöf, Frederik Böetius Hertz, Christian Østergaard Andersen, Ejvind Frausing Hansen, Jens Otto Jarløv & Jens-Ulrik Stæhr Jensen. (2021) Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients. Respiratory Research 22:1.
Crossref
Aline Fastrès, Bernard Taminiau, Emilie Vangrinsven, Alexandru-Cosmin Tutunaru, Evelyne Moyse, Frederic Farnir, Georges Daube & Cécile Clercx. (2019) Effect of an antimicrobial drug on lung microbiota in healthy dogs. Heliyon 5:11, pages e02802.
Crossref
Naseem A Charoo, Ziyaur Rahman & Areeg Anwer Ali. (2018) Is the demonstration of bioequivalence for clavulanic acid required in amoxicillin–clavulanic acid orally administered immediate-release products?. Journal of Pharmacy and Pharmacology 70:7, pages 883-892.
Crossref